The significance of proteomics in public health;La importancia de la proteómica en la salud pública

Salud Publica de Mexico

Volumn 51, Issue SUPPL.3, 2009, Pages

  Pando Robles, Rosa Victoria ^a   Lanz Mendoza, Humberto ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Mass spectrometry; Proteomics; Public health

Indexed keywords

BIOLOGICAL MARKER;

HUMAN; INFECTION; PROTEOMICS; PUBLIC HEALTH; REVIEW;

BIOLOGICAL MARKERS; HUMANS; INFECTION; PROTEOMICS; PUBLIC HEALTH;

EID: 77957002551     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342009000900004     Document Type: Article

References (76)

1. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003;422:198-207.
2. Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004;5:101-113.
3. Bork L, Serrano BL. Towards cellular systems in 4D. Cell 2005;121:507-509.
4. Hollywood K, Brison DR, Goodacre R. Metabolomics: current technologies and future trends. Proteomics 2006;6:4716-4723.
5. Van der Greef J, Stroobant P, van der Heijden R. The role of analytical sciences in medical systems biology. Curr Opin Chem Biol 2004;8:559-565.
6. Disponible en: http://www.ncbi.nlm.nih.gov/entrez/genome. Acceso: marzo 2009.
7. Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 1996;13:19-50.
8. Williams KL. Genomes and proteomes: towards a multidimensional view of biology. Electrophoresis 1999;20:678-688.
9. Disponible en: www.abrf.org/index.cfm/dm.home. Acceso: marzo 2009.
10. Hanash S. Disease proteomics. Nature 2003;422:226-232.
11. Steen H, Mann M. The ABC's (and XYZ's) of peptide sequencing. Nat Rev Mol Cell Biol 2004;5(9):699-711.
12. Ziuzdak G. Mass spectrometry and biotechnology. San Diego, California: Academic Press, 1996.
13. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989;246:64-71.
14. Tanaka K, Waki H, Ido Y, Akita S, Yoshida Y, Yoshida T. Protein and polymer analysis up to m/z 100,000 by laser ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1988;2:151.
15. Bradshaw RA, Burlingame AL. From proteins to proteomics. IUBMB Life 2005;57:267-272.
16. Huber LA. Is proteomics heading in the wrong direction?. Nat Rev Mol Cell Biol 2003;4:74-80.
17. de Hoog CL, Mann M. Proteomics. Annu Rev Genomics Hum Genet 2004;5:267-293.
18. Pando V, Batista CVF. Capítulo Proteómica: hacia el entendimiento del lenguaje de las proteínas. En: Rebolledo F, López Munguía A. (eds). Una ventana al quehacer científico. México: UNAM, Instituto de Biotecnología, 2008:97-108.
19. Sauer S, Lechner D, Berlin K, Lehrach H, Escary JL, Fox N, et al. A novel procedure for efficient genotyping of single nucleotide polymorphisms. Nucleic Acids Res 2000;28(5):E13.
20. Briese T, Palacios G, Kokoris M, Jabado O, Liu Z, Renwick N, et al. Diagnostic system for rapid and sensitive differential detection of pathogens. Emerg Infect Dis 2005;11:310.
21. Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 2008;5(10):588-599.
22. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005;5(11):845-856.
23. Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 2007;6:25.
24. Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 2005;4(4):409-418.
25. Bermudez-Crespo J, López, JL. A better understanding of molecular mechanisms underlying human disease. Proteomics Clin Appl 2007;1:983-1003.
26. Disponible en: http://www.fda.gov. Acceso: marzo 2009.
27. Mueller J, von Eggeling F, Driesch D, Schubert J, Melle C, Junker K. ProteinChip technology reveals distinctive protein expression profiles in the urine of bladder cancer patients. Eur Urol 2005;47(6):885-893
28. Soloway MS, Briggman V, Carpinito GA, Chodak GW, Church PA, Lamm DL, et al. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 1996;156(2 Pt 1):363-367.
29. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48(8):1296-1304.
30. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984;3(3):223-232.
31. Hilkens J, Buijs F, Hilgers J, Hageman P, Calafat J, Sonnenberg A, et al. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 1984;34(2):197-206.
32. Chen YD, Zheng S, Yu JK, Hu X. Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 2004;10(24):8380-8385.
33. Poon TC, Sung JJ, Chow SM, Ng EK, Yu AC, Chu ES, et al. Diagnosis of gastric cancer by serum proteomic fingerprinting. Gastroenterology 2006;130(6):1858-1864.
34. Ward DG, Cheng Y, N'Kontchou G, Thar TT, Barget N, Wei W, et al. Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br J Cancer 2006;94(2):287-292.
35. Abelev GI, Perova SD, Khramkova NI, Postnikova ZA, Irlin IS. Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation 1963;1:174-180.
36. Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, et al. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer 2005;5:83.
37. Grenier J, Pujol JL, Guilleux F, Daures JP, Pujol H, Michel FB. Cyfra 21-1, a new marker of lung cancer. Nucl Med Biol 1994;21(3):471-476.
38. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004;64(16):5882-5890.
39. Bast RCJr. Reactivity of a monoclonal antibody with humanovarian carcinoma. J Clin Invest 1981;68:1331-1337.
40. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004;10(3):860-868.
41. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 1979;5(6):957-971.
42. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62(13):3609-3614.
43. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979;17(2):159-163.
44. Woolas, RP, Xu FJ, Jacobs Ij, Yu, Y, et al. Elevation of multiple serum markersin patients withstage I ovarian canecrs. J Natl Cancer Inst 1993:85:1748-1751.
45. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359(9306):572-577.
46. Kong F, Nicole-White C, Xiao X, Feng Y, Xu C, He D, et al. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer. Gynecol Oncol 2006;100(2):247-253.
47. Kozak KR, Amneus MW, Pusey SM, Su F, Luong MN, Luong SA, et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci U S A 2003;100(21):12343-12348.
48. Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, et al. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res 2003;9(8):2904-2911.
49. Fish RG, Gill TS, Adams M, Kerby I. Serum haptoglobin and alpha 1-acid glycoprotein as indicators of the effectiveness of cis-diamminedichloroplatinum (CDDP) in ovarian cancer patients--a preliminary report. Eur J Cancer Clin Oncol 1984;20(5):625-630.
50. Thompson S, Dargan E, Turner GA. Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett 1992;66(1):43-48.
51. Yu LR, Issaq HJ, Veenstra D. Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets. Proteomics Clin Appl 2007;1:1042-1057.
52. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295(13):1549-1555.
53. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17(1):4-12.
54. Boden G, Duan X, Homko C, Molina EJ, Song W, Perez O, et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008;57(9):2438-2444.
55. Gregor MF, Yang L, Fabbrini E, Mohammed BS, Eagon JC, Hotamisligil GS, et al. Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss. Diabetes 2009;58:693-700.
56. Sharma NK, Das SK, Mondal AK, Hackney OG, Chu WS, Kern PA, et al. Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J Clin Endocrinol Metab 2008;93(11):4532-4541.
57. Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell Biol 2004;14(1):20-28.
58. Argüello M, Montero H, López S. Una ventana al quehacer científico. 25 aniversario, Capítulo Como contienden los virus con el estrés. México: UNAM, Instituto de Biotecnología, 2008:167-176.
59. Covarruvias L, Castro S. Una ventana al quehacer científico. 25 aniversario, Capítulo Degeneración y regeneración tisular: de la embriogénesis a la medicina regenerativa. México: UNAM, Instituto de Biotecnología, 2008:145-158.
60. Gurzov EN, Ortis F, Bakiri L, Wagner EF, Eizirik DL. JunB inhibits ER stress and apoptosis in pancreatic beta cells. PLoS ONE 2008;3(8):e3030.
61. Kutlu B, Burdick D, Baxter D, Rasschaert J, Flamez D, Eizirik DL, et al. Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics 2009;2:3.
62. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2008;451(7182):1076-1081.
63. Zhang CG, Chromy BA, McCutchen-Maloney SL. Host-pathogen interactions: a proteomic view. Expert Rev Proteomics 2005;2:187-202.
64. Wu HJ, Wang AH, Jennings MP. Discovery of virulence factors of pathogenic bacteria. Curr Opin Chem Biol 2008;12(1):93-101.
65. Lee EY, Choi DS, Kim KP, Gho YS. Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spectrom Rev 2008;27(6):535-555.
66. Viswanathan K, Früh K. Viral proteomics: global evaluation of viruses and their interaction with the host. Expert Rev Proteomics 2007;4(6):815-829.
67. Maxwell KL, Frappier L. Viral proteomics. Microbiol Mol Biol Rev 2007;71(2):398-411.
68. Burgener A, Boutilier J, Wachihi C, Kimani J, Carpenter M, Westmacott G, et al. Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J Proteome Res 2008;7(10):4446-4454.
69. Paskewitz SM, Shi L. The hemolymph proteome of Anopheles gambiae. Insect Biochem Molec Biol 2005;35:815-824.
70. Pattanakitsakul SN, Rungrojcharoenkit K, Kanlaya R, Sinchaikul S, Noisakran S, Chen ST, et al. Proteomic analysis of host responses in HepG2 cells during dengue virus infection. J Proteome Res 2007;6(12):4592-4600.
71. HaffLA, Smirnov IP. Single-nucleotide polymorphism identification assays using a thermostable DNA polymerase and delayed extraction MALDI-TOF mass spectrometry. Genome Res 1997;7(4):378-388.
72. Sauer S, Lechner D, Berlin K, Lehrach H, Escary JL, Fox N, et al. A novel procedure for efficient genotyping of single nucleotide polymorphisms. Nucleic Acids Res 2000;28(5):E13.
73. Elnifro E, Ashshi A, Cooper R, Klapper P. Multiplex PCR: optimization and application in diagnostic virology. Clin Microbiol Rev 2000;13:559.
74. Palacios G, BrieseT, Kapoor V, Jabado O, Liu Z, Venter M, et al. Mass Tag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emer Infec Dis 2006;12:692.
75. Dominguez SR, Briese T, Palacios G, Hui J, Villari J, Kapoor V, et al. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol 2008;43(2):219-222.
76. Söderlund-Strand A, Dillner J, Carlson J. High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry. Clin Chem 2008;54(1):86-92. Epub 2007 Nov 2.